News

Cadence Partners with VEDP and BRCC for Job Starter Program

Cadence and several other local Shenandoah Valley, Virginia-based manufacturers are teaming up with the Virginia Economic Development Partnership (VEDP) and Blue Ridge Community College for their new Job Starter training program.  Job Starter is a paid training program that allows potential job candidates the opportunity to receive training and meet local employers during a 3-week period.  Ultimately, this program is intended to help members of the community land a career in the advanced manufacturing industry with the employer of their choice.

“It was a great experience to be part of the team of local employers that helped develop this program with Blue Ridge Community College and VEDP,” said Rachel Brown, Human Resources Manager at Cadence’s Virginia facility.  “I believe Job Starter will be an excellent resource for Shenandoah Valley residents that are interested in having a career in advanced manufacturing.”

Job Starter begins October 25 and runs through November 15.  Careers in the program include, but are not limited to, production associates, machine operators, and manufacturing apprentices.  Other local companies participating in the program are Berry Global, Daikin Applied, Dynamic Aviation, Innovative Refrigeration Systems, McKee Foods, and Provides US.

To learn more about Job Starter or to register for this inaugural program, please visit: https://www2.cadenceinc.com/BRCCjobstarter.

Recent News

10/22/2025

Virginia Catalyst Announces Round 19 of Grant Funding

The Virginia Catalyst announced today that it is accepting letters of intent (LOI) for Grant Round 19 to fund the development and commercialization of life science projects that address major unmet needs for improving human health and advance Virginia’s economy. “We at the Virginia Catalyst are pleased to provide funding in support of the Governor’s

10/21/2025

SRI multi-party team selected as an awardee by ARPA-H to develop at-home screening for ≥30 types of cancers

SRI, along with research partners Foothold Labs and Triple Ring Technologies and commercial partner Beacon Dx Health, has been awarded up to $34 million from the Advanced Research Projects Agency for Health (ARPA-H) to develop technology as part of the POSEIDON (Platform Optimizing SynBio for Early Intervention and Detection in Oncology) program. This pioneering program

10/21/2025

Quoin Pharmaceuticals Announces U.S. FDA Grants Orphan Drug Designation for QRX003 in Netherton Syndrome

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead product candidate, QRX003, for the treatment of Netherton Syndrome. The designation follows previously granted Orphan